Gastrointestinal Cancer News

University of Chicago Medicine Comprehensive Cancer Center has joined the National Comprehensive Cancer Network as its 33rd member institution.

HHS on Monday released the National Cancer Plan, which includes eight goals and strategies to prevent cancer, reduce related mortality and improve the lives of people living with the disease.

Patients in U.S. counties with higher poverty were less likely to undergo liver metastasectomy for colorectal liver metastasis, suggesting that access to surgery for complex gastrointestinal cancers may be affected by social determinants.

FDA granted full approval to pembrolizumab for treatment of certain adults and children with unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors as determined through an FDA-approved test.

Community oncologists who received peer coaching from cancer genetics experts more frequently ordered genetic testing for their patients, according to study results.

Individuals with certain germline pathogenic variants had a substantially higher risk for developing gastric cancer after Helicobacter pylori infection, results of a Japan-based case-control study showed.

Chemoradiotherapy with a contact X-ray brachytherapy boost significantly increased clinical complete response and 3-year organ preservation rates in patients with early cT2-cT3 rectal adenocarcinoma, particularly tumors smaller than 3 cm.

March is Colorectal Cancer Awareness Month; in the latest installment of our diversity, equity and inclusion video series with ASGE, Pegah Hosseini-Carroll, MD, proposed strategies for mitigating disparities in CRC screening.

For the entirety of March, the gastroenterology community has celebrated National Colorectal Cancer Awareness Month to encourage individuals to learn more about the highly preventable cancer and to increase screening.

The FDA announced several regulatory actions the past few weeks.